Zolpidem for Persistent Insomnia in SSRI-Treated Depressed Patients
The Journal of Clinical PsychiatryPublished 15 October 1999
Gregory M. Asnis, Amil Chakraburtty, E. DuBoff, Andrew D. Krystal, Peter D. Londborg, Russell Rosenberg
Citations174
SJR quartileQ1
SJR score1.49
SNIP1.38
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
In this defined patient population, zolpidem, 10 mg, was effectively and safely co-administered with an SSRI, resulting in improved self-rated sleep, daytime functioning, and well-being.
Abstract
In this defined patient population, zolpidem, 10 mg, was effectively and safely co-administered with an SSRI, resulting in improved self-rated sleep, daytime functioning, and well-being.
Keywords
Psychology